Clinical trial / 2014
Hydrolyzed infant formula did not reduce diabetes-associated autoantibodies in genetically susceptible infants.
In a randomized trial involving 2,159 infants with genetic susceptibility to type 1 diabetes, participants were assigned to an extensively hydrolyzed casein formula (n = 1,078) or conventional cow's milk formula (n = 1,081) during weaning. Over a median follow-up of 7.0 years, positivity for at least two islet autoantibodies was 13.4% versus 11.4%, yielding an adjusted hazard ratio of 1.23 (95% CI, 0.96-1.58). Extensively hydrolyzed formula did not confer protective benefits.
- Study type
- Randomized controlled trial
- Who was studied
- 2,159 infants with HLA susceptibility and a first-degree relative with type 1 diabetes
- What was measured
- Cumulative incidence of at least two diabetes-associated autoantibodies
THE PAPER
Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM, TRIGR Study Group. JAMA, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.